Cut through the noise, find the signal: Intelligence for serious healthcare leaders
Inflation Reduction Act drug provisions, Medicare drug price negotiation and MFP, Part D redesign, most-favored-nation pricing
AMCP (Academy of Managed Care Pharmacy)Topic alignment 95
CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program spassin@amcp.org Fri, 11/06/2026 - 14:43 On November 5, 2026, the Centers for Medicare and Medicaid Services issued a final rule on the…
AHATopic alignment 95
Frier LevittTopic alignment 90
The White House announced on August 31, 2026, that nine additional pharmaceutical manufacturers had signed most-favored-nation (MFN) pricing agreements with the federal government. The new signatories include Alcon, Astellas Pharma, BeOne Medicines,…
The Center for BiosimilarsTopic alignment 92
Juliana Reed, MS, of the Biosimilars Forum explains how a proposed bill would define "high likelihood" and delay Medicare negotiation for biologics.
KFFTopic alignment 88
Medicare Part D is a voluntary outpatient prescription drug benefit for people with Medicare provided through private plans, including stand-alone prescription drug plans and Medicare Advantage plans that offer drug coverage. This analysis provides an…
KFF Health NewsTopic alignment 85
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase by switching to lower-cost plans.
Endpoints NewsTopic alignment 85
Bayer CEO Bill Anderson said the drugmaker is “working on” a most favored nation agreement, signaling that it is in talks with President Donald Trump’s administration. The German drugmaker was not part ...
Arnold VenturesTopic alignment 92
USC SchaefferTopic alignment 86
Becker's Hospital ReviewTopic alignment 90